Bonumose, Inc.

Bonumose is an early-stage food ingredient manufacturer that uses a proprietary enzymatic technology platform to produce affordable, healthy rare sugars at commercial scale. Founded on a breakthrough by Chief Scientific Officer Dr. Daniel Wichelecki, Bonumose's core product is tagatose — a naturally-occurring rare sugar with 92% the sweetness of sucrose, a glycemic index of just 3, and prebiotic gut health benefits. The company's enzymatic process starts from low-cost, plant-based starch feedstocks (unlike legacy milk-derived methods), achieving extremely high yields at a fraction of traditional costs. Beyond tagatose, Bonumose is expanding its portfolio to include allulose, allose, D-mannose, and other functional food ingredients. Headquartered in Charlottesville, Virginia, Bonumose sells to food and beverage manufacturers seeking to replace conventional sweeteners without taste trade-offs.